176
Views
18
CrossRef citations to date
0
Altmetric
Review

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

, , &
Pages 285-299 | Published online: 29 Jun 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos & Michael Koutsilieris. (2013) Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opinion on Investigational Drugs 22:11, pages 1385-1400.
Read now
Pavlos Msaouel, Evanthia Galanis & Michael Koutsilieris. (2009) Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology. Expert Opinion on Investigational Drugs 18:9, pages 1297-1316.
Read now

Articles from other publishers (16)

Pamela Taxel. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1407 1419 .
Fabrizio Fontana, Monica Marzagalli, Marina Montagnani Marelli, Michela Raimondi, Roberta Moretti & Patrizia Limonta. (2020) Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions. International Journal of Molecular Sciences 21:24, pages 9511.
Crossref
Simon Walz, Moritz Maas, Arnulf Stenzl & Tilman Todenhöfer. (2020) Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review. The World Journal of Men's Health 38:2, pages 151.
Crossref
Catherine Poznak & Pamela Taxel. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 775 780 .
Pamela Taxel, Erika Faircloth, Sana Idrees & Catherine Van Poznak. (2018) Cancer Treatment–Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer. Journal of the Endocrine Society 2:7, pages 574-588.
Crossref
Konstantinos Kamposioras & Evangelos Briasoulis. 2014. Bone Metastases. Bone Metastases 247 273 .
Kazuhiro Miwa, Takenori Hitaka, Takashi Imada, Satoshi Sasaki, Mie Yoshimatsu, Masami Kusaka, Akira Tanaka, Daisuke Nakata, Shuichi Furuya, Satoshi Endo, Kazumasa Hamamura & Tomoyuki Kitazaki. (2011) Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3- d ]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor . Journal of Medicinal Chemistry 54:14, pages 4998-5012.
Crossref
Yi Jiang, Ze-Hong Miao, Lei Xu, Bing Yu, Jing-Xu Gong, Lin-Jiang Tong, Yi Chen, Zhao-Li Zhou, Hong-Chun Liu, Yi Wang, Yue-Wei Guo & Jian Ding. (2011) Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction. Journal of Biological Chemistry 286:30, pages 26461-26469.
Crossref
Soe T. Maunglay, Julia A. Cogburn & Pamela N. Munster. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures 165 190 .
Joanna Beate Korda & Frank Sommer. (2010) Die antiandrogene Therapie aus urologischer SichtAnti-androgen treatment of paraphilias from the urologist’s perspective. Forensische Psychiatrie, Psychologie, Kriminologie 4:S1, pages 17-21.
Crossref
Richard Aspinall & Wayne A. Mitchell. 2010. The Future of Aging. The Future of Aging 489 520 .
Pavlos MsaouelEvanthia Galanis. (2009) Measles virotherapy in prostate cancer treatment: a novel antitumor approach. Future Virology 4:3, pages 203-207.
Crossref
Konstantinos Kamposioras & Evangelos Briasoulis. 2009. Bone Metastases. Bone Metastases 299 320 .
Richard Aspinall & Wayne Mitchell. (2008) Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects. Experimental Gerontology 43:7, pages 700-705.
Crossref
Pavlos Msaouel, Nikos Pissimissis, Antonios Halapas & Michael Koutsilieris. (2008) Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism 22:2, pages 341-355.
Crossref
Alba Minelli, Ilaria Bellezza, Arianna Tucci, Carmela Conte, Sergio Bracarda & Zoran Culig. (2008) 2‐Chloroadenosine modulates PAR‐1 and IL‐23 expression and enhances docetaxel effects on PC3 cells. The Prostate 68:4, pages 360-372.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.